These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 6155632)
1. [Experimental vasospasms--significance of oxyhemoglobin, fibrin degradation products and breakdown products of white ghost in the pathogenesis of cerebral vasospasms. Treatment of vasospasms with gabexate mesilate and diphenhydramine (author's transl)]. Ito M Neurol Med Chir (Tokyo); 1980 Mar; 20(3):225-36. PubMed ID: 6155632 [No Abstract] [Full Text] [Related]
2. [The relation between cerebral vasospasms and superoxide--application of an experimental model of Vasospasms induced by Oxyhemoglobin in cats (author's transl)]. Kamiyama K; Okada H; Suzuki J Neurol Med Chir (Tokyo); 1981 Feb; 21(2):201-9. PubMed ID: 6164943 [No Abstract] [Full Text] [Related]
3. [Experimental studies on fibrinolytic activity and angiospasm following subarachnoid hemorrhage in dogs (author's transl)]. Yoshida Y Nihon Geka Hokan; 1978 Sep; 47(5):537-62. PubMed ID: 152615 [No Abstract] [Full Text] [Related]
4. [Application of gabexate mesilate on measurement of coagulation and fibrinolysis. --The effect of high molecular weight Fbg/Fb complex in plasma-- (author's transl)]. Suzuki S; Tahara C; Kazama M Rinsho Byori; 1981 Apr; 29(4):404-8. PubMed ID: 6798246 [No Abstract] [Full Text] [Related]
5. [Lipid peroxidation and cerebral vasospasm (author's transl)]. Asano T; Sasaki T; Sano K No To Shinkei; 1981 Jan; 33(1):33-46. PubMed ID: 7470332 [No Abstract] [Full Text] [Related]
6. [An experimental study on intrathecal injection of fibrinolytic agent for angiospasm following subarachnoid hemorrhage in the dogs (author's transl)]. Yoshida Y; Handa H; Hayashi T; Amo M; Aoki M; Kusuno K; Lee E; Uno T Nihon Geka Hokan; 1979 Mar; 48(2):188-96. PubMed ID: 162263 [No Abstract] [Full Text] [Related]
7. [Current management of cerebral vasospasm (author's transl)]. Ohmoto T No Shinkei Geka; 1978 Mar; 6(3):229-34. PubMed ID: 347323 [No Abstract] [Full Text] [Related]
10. [Morphological changes in cerebral vessels in experimental cerebral vasospasms (author's transl)]. Yoshioka J; Yabuno N; Morooka H; Matsumoto Y; Ohmoto T; Nishimoto A Neurol Med Chir (Tokyo); 1981 Feb; 21(2):211-9. PubMed ID: 6164944 [No Abstract] [Full Text] [Related]
11. [Etiology and treatment of prolonged vasospasm --experimental and clinical studies-- (author's transl)]. Miyaoka M; Nonaka T; Watanabe H; Chigasaki H; Ishi S Neurol Med Chir (Tokyo); 1976 Mar; 16(2 pt 2):103-14. PubMed ID: 62289 [No Abstract] [Full Text] [Related]
12. [Basic research on cerebral vasospasms --calcium localization in cerebral vascular smooth muscle (author's transl)]. Fukuoka H; Takagi T; Nagai H; Hotta K Neurol Med Chir (Tokyo); 1981 Jun; 21(6):547-53. PubMed ID: 6167876 [No Abstract] [Full Text] [Related]
13. [Prognostic value of cerebrospinal fluid fibrinolytic activity in meningeal hemorrhages as a result of aneurysm rupture]. Rivierez M; Dagreou F; Guggiari M; Ankri A; Crespo B; Philippon J Neurochirurgie; 1983; 29(2):119-23. PubMed ID: 6888630 [TBL] [Abstract][Full Text] [Related]
14. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis. Dabrowski A; Gabryelewicz A J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457 [TBL] [Abstract][Full Text] [Related]
15. Serine protease inhibitors nafamostat mesilate and gabexate mesilate attenuate allergen-induced airway inflammation and eosinophilia in a murine model of asthma. Chen CL; Wang SD; Zeng ZY; Lin KJ; Kao ST; Tani T; Yu CK; Wang JY J Allergy Clin Immunol; 2006 Jul; 118(1):105-12. PubMed ID: 16815145 [TBL] [Abstract][Full Text] [Related]
16. [Critical flow levels in cerebral ischemia--II. Vasospasm following subarachnoid hemorrhage (author's transl)]. Kawase T; Mizukami M; Tazawa T; Araki G No To Shinkei; 1981 Jan; 33(1):61-9. PubMed ID: 7470333 [No Abstract] [Full Text] [Related]
17. Strongly increased levels of fibrinogen elastase degradation products in patients with ischemic stroke. de Lau LM; Cheung EY; Kluft C; Leebeek FW; Meijer P; Laterveer R; Dippel DW; de Maat MP Br J Haematol; 2008 Dec; 143(5):734-7. PubMed ID: 19036017 [TBL] [Abstract][Full Text] [Related]
18. [Examination of fibrin degradation products in cirrhosis of liver (author's transl)]. Pstruzinová H; Rovenská A; Goderová Z; Kristan M Cas Lek Cesk; 1980 Jan; 119(1):7-11. PubMed ID: 7371051 [No Abstract] [Full Text] [Related]
19. [Distinction between fibrinogen and fibrin degradation products in serum from patients with DIC (author's transl)]. Yoshioka K; Yamamoto T; Yamauchi E; Mizuno S; Miyata H Rinsho Ketsueki; 1981 Sep; 22(9):1401-5. PubMed ID: 7334618 [No Abstract] [Full Text] [Related]
20. [Determination of plasma fibrinogen and fibrin degradation products (FDP) in 100 normal persons and 32 cases of acute cerebrovascular disease (author's transl)]. Wang GX Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):8-10. PubMed ID: 7094732 [No Abstract] [Full Text] [Related] [Next] [New Search]